Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$30.45 USD
+0.22 (0.73%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $30.44 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $0.90 | 6.67% |
Earnings Summary
For their last quarter, Royalty Pharma (RPRX) reported earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.03 per share. This reflects a positive earnings surprise of 11.65%. Look out for RPRX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of $0.90 per share, reflecting a year-over-year decrease of 43.75%.
Earnings History
Price & Consensus
Zacks News for RPRX
RPRX or BX: Which Is the Better Value Stock Right Now?
RPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services